Enquiry/Quote
Ceftazidime Injection bulk supplier for pharma manufacturers

Ceftazidime Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 250mg, 1000mg

Reference Brands: Fortaz (USA), Fortum(EU/UK), Tazicef (USA)

Category: Antibiotics

Ceftazidime injection is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth. However, this medicine will not work for colds, flu, or other virus infections. Ceftazidime Injection is available in Injection and strengths such as 250mg, 1000mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ceftazidime Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Ceftazidime Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Ceftazidime is a third-generation cephalosporin antibiotic sold under the brand name Fortaz and other regional brands. It is widely used to treat a broad spectrum of bacterial infections caused by susceptible organisms. Ceftazidime is particularly effective against Gram-negative bacteria, including Pseudomonas aeruginosa, making it an important option for difficult-to-treat infections.

It is indicated for the treatment of lower respiratory tract infections, skin and soft tissue infections, urinary tract infections, bloodstream infections, joint infections, intra-abdominal infections, and meningitis. It is also used for specific infections such as malignant otitis externa and Vibrio infections. By interfering with bacterial cell wall synthesis, ceftazidime inhibits bacterial growth and promotes cell death, helping to resolve infections efficiently.

Ceftazidime is a versatile antibiotic used in hospitals and clinical settings worldwide and is available under various brand names and generics. It is reserved for moderate to severe infections where effective therapy against resistant Gram-negative bacteria is required, and its use is guided by local antimicrobial susceptibility patterns and clinical judgment.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Ceftazidime is an antibiotic used to treat a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and bloodstream infections. It is especially effective against Gram-negative bacteria, including Pseudomonas aeruginosa.

Ceftazidime is made from the active pharmaceutical ingredient ceftazidime, which belongs to the third-generation cephalosporin class of antibiotics. It works by interfering with bacterial cell wall synthesis, leading to bacterial cell death.

Common trade names include Fortaz, Ceptaz, and Tazicef.

Ceftazidime is manufactured by multiple pharmaceutical companies worldwide. The original brand Fortaz is marketed by GlaxoSmithKline (GSK) in some regions, while generic versions are produced by various other manufacturers.

The generic name is ceftazidime.

Brand names include Fortaz, Ceptaz, and Tazicef, along with multiple regional generics.

Ceftazidime is manufactured in regulated pharmaceutical facilities in the USA, EU, UK, India, and other countries depending on the manufacturer and marketing authorization holder.

Yes, Ceftazidime Injection is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Ceftazidime Injection is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Ceftaroline

Strength:
600 mg

Form: Injection

Reference Brands: Teflaro (USA), Zinforo (EU)

View Details
Secnidazole

Strength:
2 g

Form: Oral granules/ tablets

Reference Brands: Solosec (USA)

View Details
Omaveloxolone

Strength:
150 mg

Form: Tablets

Reference Brands: Skyclarys (USA)

View Details
Tedizolid Phosphate

Strength:
200 mg

Form: Tablet / Injection

Reference Brands: Sivextro (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.